Rankings
▼
Calendar
▼
INBS Q2 2018 Earnings Report — Intelligent Bio Solutions Inc. Revenue & Financial Results | Market Cap Arena
Intelligent Bio Solutions Inc.
INBS
Q2 2018 Earnings
Reported December 31, 2017
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q2 2018
Q1 2018
Q2 2017
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$1M
-$1M
—
-33.2%
—
EPS (Diluted)
$-436.90
$-336.30
—
-29.9%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$787.1K
Selling & Marketing
$5.8K
General & Administrative
$575.3K
SG&A Expenses
$581.1K
Other Expenses
$0
Operating Expenses
$1M
Cost & Expenses
$1M
OPERATING INCOME
-$1M
Interest Income
$0
Interest Expense
$134.0K
Other Income/Expenses
-$134.0K
INCOME BEFORE TAX
-$2M
Income Tax Expense
$0
Net Income from Continuing Ops
-$2M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$2M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$2M
D&A
$1M
EBIT
-$1M
EBITDA
$0
EPS
-$437
EPS Diluted
-$437
marketcaparena.com
← FY 2018
INBS Overview
Q3 2018 →